Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
298.23
Oct 30 • 3:59 PM ET Dollar change-0.18 Percentage change(-0.06%)
Aftermarket Close
301.48
Aftermarket • 7:48 PM ET Dollar change+3.25 Percentage change(1.09%)
Index
S&P 500
Market Cap
78.80B
Enterprise Value
-
Income
6.42B
Sales
282.50B
Book/sh
161.62
Cash/sh
-
Employees
67700
IPO
May 16, 1979
P/E
12.33
Forward P/E
8.91
PEG
1.18
P/S
0.28
P/B
1.85
P/C
-
P/FCF
8.65
EV/EBITDA
-
EV/Sales
-
Quick Ratio
-
Current Ratio
0.85
Debt/Eq
0.75
LT Debt/Eq
0.68
Option/Short
Yes / Yes
EPS (ttm)
24.18
EPS next Y
33.49
EPS next Q
7.52
EPS this Y
2.25%
EPS next Y
9.76%
EPS next 5Y
7.57%
EPS past 3/5Y
1.18% -0.69%
Sales past 3/5Y
15.15% 11.35%
EPS Y/Y TTM
31.47%
Sales Y/Y TTM
8.15%
EPS Q/Q
10.08%
Sales Q/Q
6.50%
Insider Own
1.50%
Insider Trans
-5.38%
Inst Own
93.06%
Inst Trans
-0.23%
ROA
4.27%
ROE
15.49%
ROIC
8.95%
Gross Margin
-
Oper. Margin
3.86%
Profit Margin
2.27%
SMA20
1.57%
SMA50
5.04%
SMA200
5.89%
Trades
Shs Outstand
263.70M
Shs Float
260.27M
52W High
316.27 -5.70%
52W Low
239.51 24.52%
Volatility
2.23% 2.41%
ATR (14)
7.35
RSI (14)
55.62
Beta
0.28
Rel Volume
1.14
Avg Volume
1.63M
Volume
1,862,175
Perf Week
-2.84%
Perf Month
11.30%
Perf Quarter
5.73%
Perf Half Y
5.42%
Perf YTD
8.36%
Perf Year
20.69%
Perf 3Y
-2.29%
Perf 5Y
39.61%
Perf 10Y
145.21%
Prev Close
298.41
Price
298.23
Change %
-0.06%
Consensus
Buy
Avg. Price Target
$342.09
Implied Upside
+14.7%
Analysts13incl. previous ratings
Rating Distribution8 Buy · 5 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Sep 09, 2026Initiated
EVR logoEEvercore ISI
In-line$290-2.8%
Aug 04, 2026Downgrade
JEF logoJJefferies
Buy → Hold$307+2.9%
Aug 03, 2026Downgrade
RJF logoRRaymond James
Strong Buy → Outperform$320+7.3%
May 26, 2026Downgrade
BCS logoBBarclays
Overweight → Equal Weight$304+1.9%
May 20, 2026Downgrade
DB logoDDeutsche Bank
Buy → Hold$302+1.3%
Mar 12, 2026Upgrade
BBernstein
Mkt Perform → Outperform$358+20.0%
Oct 14, 2025Initiated
GS logoGGoldman
Buy$370+24.1%
Feb 06, 2025Downgrade
BBernstein
Outperform → Mkt Perform$323+8.3%
Jun 26, 2024Initiated
PPiper Sandler
Overweight$400+34.1%
May 30, 2024Initiated
RRobert W. Baird
Outperform$388+30.1%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Neville EverettSee RemarksSep 03 '26Sale284.05617175,2595,053Sep 08 04:29 PM
Neville EverettOfficerSep 03 '26Proposed Sale284.05617175,259Sep 03 11:08 AM
Jones Nicole SSee RemarksAug 18 '26Sale279.612,677748,51625,880Aug 20 05:07 PM
Jones Nicole SOfficerAug 18 '26Proposed Sale279.572,677748,416Aug 18 11:40 AM
Jones Nicole SSee RemarksAug 04 '26Option Exercise192.0214,0452,696,92146,692Aug 06 04:31 PM
Jones Nicole SSee RemarksAug 05 '26Option Exercise192.021,301249,81828,557Aug 06 04:31 PM
Jones Nicole SSee RemarksAug 04 '26Sale276.2719,4365,369,58427,256Aug 06 04:31 PM
Jones Nicole SOfficerAug 04 '26Proposed Sale276.2719,4365,369,584Aug 04 01:48 PM
Kates Jamie GChief Accounting OfficerJun 12 '26Option Exercise152.89899137,4523,267Jun 16 05:05 PM
Kates Jamie GChief Accounting OfficerJun 12 '26Sale298.61899268,4522,368Jun 16 05:05 PM
Kates Jamie GOfficerJun 12 '26Proposed Sale298.61899268,452Jun 12 04:36 PM
Cordani DavidChairman & CEOMay 12 '26Option Exercise170.94189,11432,326,815236,215May 14 04:47 PM
Cordani DavidChairman & CEOMay 13 '26Option Exercise165.5423,4293,878,40657,766May 14 04:47 PM
Cordani DavidChairman & CEOMay 12 '26Sale292.82201,87859,114,18634,337May 14 04:47 PM
Cordani DavidOfficerMay 12 '26Proposed Sale292.82201,87859,114,186May 12 04:18 PM
Neville EverettSee RemarksMar 02 '26Sale288.911,719496,6365,670Mar 03 07:18 PM
Jones Nicole SSee RemarksMar 02 '26Sale288.912,307666,51532,647Mar 03 07:18 PM
Jones Nicole SOfficerMar 02 '26Proposed Sale288.912,307666,515Mar 02 01:30 PM
Neville EverettOfficerMar 02 '26Proposed Sale288.911,719496,636Mar 02 11:23 AM
Granger ElderFormer DirectorFeb 06 '26Proposed Sale293.326,1091,791,895Feb 06 02:05 PM
Cordani DavidChairman & CEONov 03 '25Buy241.884,134999,916157,935Nov 03 02:47 PM
The Cigna Group is a global health company, which engages in the provision of global health services. It operates through the following segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment partners with health plans, employers, governmental organizations, and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. The Cigna Healthcare segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. The company was founded in 1792 and is headquartered in Bloomfield, CT.
Executive Chairman of the BoardMr. David Michael Cordani
PresidentMr. Brian Case Evanko C.F.A.
Executive VP & CFOMs. Ann M. Dennison
Executive Vice PresidentMs. Nicole Susan Jones J.D.
Executive VP & Special Advisor to the CEOMr. F. Everett Neville